SYShuansuo Yang

Shuansuo Yang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shuansuo Yang has a total of 24 co-authors. Here are the top co-authors by number of shared publications:

  • Hua Liu

    Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiaotong University, NO.241, Huaihai Xi Road, Xuhui District, Shanghai, 200030, China

    2 shared publications
  • Hui Chen

    Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiaotong University, NO.241, Huaihai Xi Road, Xuhui District, Shanghai, 200030, China

    2 shared publications
  • Jinjie Dai

    Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiaotong University, NO.241, Huaihai Xi Road, Xuhui District, Shanghai, 200030, China

    2 shared publications
  • Lei Tang

    School of Medical Graduate, Shanghai Jiaotong University, Shanghai, 200025, China

    2 shared publications
  • Qian Gan

    Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiaotong University, NO.241, Huaihai Xi Road, Xuhui District, Shanghai, 200030, China

    2 shared publications
  • Ruogu Li

    Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiaotong University, NO.241, Huaihai Xi Road, Xuhui District, Shanghai, 200030, China

    2 shared publications

Latest Publications

  • Retraction
    Open Access

    Retraction Note: Meta-analysis of the effect of percutaneous coronary intervention on chronic total coronary occlusions

    by Ruogu Li, Shuansuo Yang, Lei Tang, Yiqing Yang, Hui Chen, Shaofeng Guan, Wenzheng Han, Hua Liu, Jinjie Dai, Qian Gan, et al.

  • Retracted
    Open Access

    RETRACTED ARTICLE: Meta-analysis of the effect of percutaneous coronary intervention on chronic total coronary occlusions

    by Ruogu Li, Shuansuo Yang, Lei Tang, Yiqing Yang, Hui Chen, Shaofeng Guan, Wenzheng Han, Hua Liu, Jinjie Dai, Qian Gan, et al.

    Background and purpose: Coronary chronic total occlusion (CTO) is the last stage of coronary artery atherosclerosis. Percutaneous coronary intervention (PCI) is a therapeutic procedure used to recanalize vessels with total occlusion. However, successful recanalization of CTO is still not optimal, and the key influence factors are still uncertainty. Therefore, a scientific evaluation on the effective of PCI for CTO treatment is necessary. Methods: Relevant studies of PCI treatment for CTO were examined. Data were extracted and assessed by two independent clinical experts. Embase, PubMed and Medline et al. were used as database. The main research key words include “CTO”, “PCI”, “Stent”, “Reopen”, “long-term”, “follow-up” and “outcome”. Quality assessment was carried out according to the Cochrane Handbook. The selected data were pooled and analyzed using fixed-effect model and random-effect model. Heterogeneity was assessed using the I 2 test, Q test, L’abbe and Galbraith. Comprehensive Meta -Analysis 2.0 and Metanalysis 1.0 were used for statistics analysis in this research. Results: A total of 16 articles involving 6695 cases in successful CTO recanalization (CTO success group) and 2370 cases in failed CTO recanalization(CTO failure group) were included in this research. Low CTO success was associated with elder age, previous coronary artery bypass graft surgery (CABG) history, multi-vessel diseases and right coronary artery disease lesion. Six follow-up variables including major adverse cardiac events (MACE), recurrent myocardial infarction (MI), all-cause death, incidence of angina, subsequent CABG and cumulative survival rate were found significantly reduced associated with CTO success. Conclusions: Clinical baseline characteristics such as age, previous CABG history and lesion baseline characteristics such as lesion length, multi-vessel diseases might be important factors influencing the successful rate of CTO recanalization. Compared to CTO failure patients, all six follow-up variables showed advantage for CTO success patients.


    • 1 January 2014
      • Vol. 35  (1) , 80-6

    The effects of subclinical hypothyroidism on serum lipid level and TLR4 expression of monocyte in peripheral blood of rats.

    by Shuan-Suo Yang, Lei Tang, Ruo-Gu Li, Guang-Hao Ge, Xin-Kai Qu, Jiang-Wei Ma, Zeng-Yong Qiao, Li Zhang, Hua-Jin Liu, Yue-Mei Hou, et al.

    To observe effect of subclinical hypothyroidism (SCH) on serum lipid level and expression of toll-like receptor 4 (TLR4) in rats' peripheral blood mononuclear cells (PBMC). Fifty Wistar female rats were divided into three groups: normal control (NC group; n=10), sham group (n=10), and L-T-4 (L-thyroxine) group (n=30, with thyroidectomy, fed with rich-calcium water after operation. 5 weeks later, abdominal subcutaneous injection of L-T-4: 0.95 μg/100g/d). 8 weeks later, the rats were killed then the peripheral blood was collected to determine the levels of serum thyroid-stimulating hormone (TSH), total thyroid hormone (TT4), total cholesterol (TC) and low density lipoprotein cholesterin (LDL-C). Rats in L-T-4 group were divided into normal lipid (NL) group) and high lipid (HL) group) according to lipid value of NC group. Monocytes were separated from blood to determine TLR4 expression by flow cytometry. In NL and HL groups TSH were higher than in NC and Sham groups (p0.05). TLR4, TLR4 mRNA, NF-κB (p65) were increased (p0.05). TLR4, TLR4 mRNA, NF-κB (p65) of PBMC and TNF-α, IL-6, IL-1β expression in serum were all increased in SCH rats, which was not related to serum dyslipidemia.